Search Results - "Byer, Stephanie"

Refine Results
  1. 1

    4-Hydroxytamoxifen Induces Autophagic Death through K-Ras Degradation by KOHLI, Latika, KAZA, Niroop, CORIC, Tatjana, BYER, Stephanie J, BRASSIER, Nicole M, KLOCKE, Barbara J, BJORNSTI, Mary-Ann, CARROLL, Steven L, ROTH, Kevin A

    Published in Cancer research (Chicago, Ill.) (15-07-2013)
    “…Tamoxifen is widely used to treat estrogen receptor-positive breast cancer. Recent findings that tamoxifen and its derivative 4-hydroxytamoxifen (OHT) can…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis by Brosius, Stephanie N., Turk, Amy N., Byer, Stephanie J., Brossier, Nicole M., Kohli, Latika, Whitmire, Amber, Mikhail, Fady M., Roth, Kevin A., Carroll, Steven L.

    Published in Acta neuropathologica (01-04-2014)
    “…Malignant peripheral nerve sheath tumors (MPNSTs) are Schwann cell-derived malignancies that arise from plexiform neurofibromas in patients with mutation of…”
    Get full text
    Journal Article
  6. 6

    Neuregulin-1β and neuregulin-1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells by Eckert, Jenell M., Byer, Stephanie J., Clodfelder-Miller, Buffie J., Carroll, Steven L.

    Published in Glia (01-11-2009)
    “…Malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy associated with neurofibromatosis Type 1 (NF1). These Schwann cell…”
    Get full text
    Journal Article
  7. 7

    Malignant Peripheral Nerve Sheath Tumor Invasion Requires Aberrantly Expressed EGF Receptors and Is Variably Enhanced by Multiple EGF Family Ligands by Byer, Stephanie J, Brossier, Nicole M, Peavler, Lafe T, Eckert, Jenell M, Watkins, Stacey, Roth, Kevin A, Carroll, Steven L

    “…ABSTRACTAberrant epidermal growth factor receptor (EGFR) expression promotes the pathogenesis of malignant peripheral nerve sheath tumors (MPNSTs), the most…”
    Get full text
    Journal Article
  8. 8

    Activation of the neuregulin-1 ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors by STONECYPHER, Mark S, BYER, Stephanie J, GRIZZLE, William E, CARROLL, Steven L

    Published in Oncogene (25-08-2005)
    “…Patients with neurofibromatosis type 1 develop aggressive Schwann cell neoplasms known as malignant peripheral nerve sheath tumors (MPNSTs). Although tumor…”
    Get full text
    Journal Article
  9. 9

    Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner by Byer, Stephanie J., Eckert, Jenell M., Brossier, Nicole M., Clodfelder-Miller, Buffie J., Turk, Amy N., Carroll, Andrew J., Kappes, John C., Zinn, Kurt R., Prasain, Jeevan K., Carroll, Steven L.

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2011)
    “…Few therapeutic options are available for malignant peripheral nerve sheath tumors (MPNSTs), the most common malignancy associated with neurofibromatosis type…”
    Get full text
    Journal Article
  10. 10

    Neuregulin Growth Factors and Their ErbB Receptors Form a Potential Signaling Network for Schwannoma Tumorigenesis by Stonecypher, Mark S, Chaudhury, Abhik Ray, Byer, Stephanie J, Carroll, Steven L

    “…Sporadic and neurofibromatosis type 2-associated schwannomas contain a glial growth factor (GGF)-like activity that has been hypothesized to promote neoplastic…”
    Get full text
    Journal Article
  11. 11

    Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents by Turk, Amy N, Byer, Stephanie J, Zinn, Kurt R, Carroll, Steven L

    Published in Journal of visualized experiments (07-03-2011)
    “…Although in vitro screens are essential for the initial identification of candidate therapeutic agents, a rigorous assessment of the drug's ability to inhibit…”
    Get full text
    Journal Article
  12. 12

    Ganglion-Specific Patterns of Diabetes-Modulated Gene Expression Are Established in Prevertebral and Paravertebral Sympathetic Ganglia Prior to the Development of Neuroaxonal Dystrophy by CARROLL, STEVEN L, BYER, STEPHANIE J, DORSEY, DENISE A, WATSON, MARK A, SCHMIDT, ROBERT E

    “…In both humans and animal models, diabetic sympathetic autonomic neuropathy is associated with the selective development of markedly enlarged distal axons and…”
    Get full text
    Journal Article
  13. 13

    R‐Ras Subfamily Proteins Elicit Distinct Physiologic Effects and Phosphoproteome Alterations in Neurofibromin‐Null MPNST Cells by Prechtl, Amanda, Brossier, Nicole, Barnes, Stephen, Wilson, Landon, Brosius, Stephanie, Byer, Stephanie, Carroll, Steven

    Published in The FASEB journal (01-04-2016)
    “…Abstract only Loss of the Ras GTPase‐activating protein neurofibromin promotes the development of multiple nervous system tumors in patients with the genetic…”
    Get full text
    Journal Article
  14. 14

    Overexpression of the lysophosphatidic acid generating enzyme autotaxin/ENPP2 potentially promotes the pathogenesis of neurofibromatosis type 1‐associated neurofibromas and malignant peripheral nerve sheath tumors by Peavler, Lafe Timothy, Byer, Stephanie J., Roth, Kevin A., Carroll, Steven L.

    Published in The FASEB journal (01-04-2013)
    “…Abstract only Aggressive Schwann cell‐derived sarcomas known as malignant peripheral nerve sheath tumors (MPNSTs) are the leading cause of death in patients…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Neuregulin‐1 overexpression and p53 haploinsufficiency cooperatively promote de novo MPNST pathogenesis by Brosius, Stephanie Nicole, Turk, Amy Nicole, Byer, Stephanie Joy, Brossier, Nicole Marie, Kohli, Latika, Roth, Kevin Aaron, Carroll, Steven Lewis

    Published in The FASEB journal (01-04-2013)
    “…Abstract only Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas arising from neurofibromas in patients with neurofibromatosis type 1…”
    Get full text
    Journal Article
  17. 17
  18. 18

    4-hydroxy-tamoxifen induces autophagic death through K-Ras degradation by Kohli, Latika, Kaza, Niroop, Coric, Tatjana, Byer, Stephanie J., Brossier, Nicole M., Klocke, Barbara J., Bjornsti, Mary-Ann, Carroll, Steven L., Roth, Kevin A.

    Published in Cancer research (Chicago, Ill.) (30-05-2013)
    “…Tamoxifen is widely used to treat estrogen receptor (ER)-positive breast cancer. Recent findings that tamoxifen and its derivative 4-dehydroxy-tamoxifen (OHT)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Neuregulin-1b and neuregulin-1a differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells by Eckert, Jenell M, Byer, Stephanie J, Clodfelder-Miller, Buffie J, Carroll, Steven L

    Published in Glia (01-11-2009)
    “…Malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy associated with neurofibromatosis Type 1 (NF1). These Schwann cell…”
    Get full text
    Journal Article